Literature DB >> 22415225

Poly(I:C) treatment influences the expression of calreticulin and profilin-1 in a human HNSCC cell line: a proteomic study.

Tanja Matijević1, Jasminka Pavelić.   

Abstract

Polyinosinic:polycytidylic acid (poly (I:C)) has been formerly known to be an interferon inducer but the mechanism of its action was not revealed until the discovery of Toll-like receptors (TLRs). TLRs are members of transmembrane proteins that recognize conserved molecular motifs of viral and bacterial origin and initiate innate immune response. Recent studies have shown that they are also expressed on tumor cells, but their role in these cells is still not clear. TLR3 recognizes double-stranded RNA (poly (I:C)) and is primarily involved in the defense against viruses. TLR3 ligand binding initiates the activation of transcription factors NF-κB, IRF family members, and AP-1, which can induce wide cascading effect on the cell and consequently activate many cellular processes. Since little is known about TLR3 target genes, we have used the proteomic approach to widen the current knowledge. In this study, we have discovered 15 differentially expressed proteins, mostly connected with protein metabolic processes. Furthermore, we have confirmed by Western blot that calreticulin and profilin-1, proteins which have been shown previously to be involved in processes connected with tumor progression, are differentially expressed after poly(I:C) treatment. By using TLR3 small interfering RNA, we showed that calreticulin expression might be TLR3 dependent, unlike profilin-1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22415225     DOI: 10.1007/s13277-012-0366-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  40 in total

Review 1.  Activators and target genes of Rel/NF-kappaB transcription factors.

Authors:  H L Pahl
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

2.  In vivo dual-tagging proteomic approach in studying signaling pathways in immune response.

Authors:  Tianyi Wang; Sheng Gu; Tapani Ronni; Yu-Chun Du; Xian Chen
Journal:  J Proteome Res       Date:  2005 May-Jun       Impact factor: 4.466

3.  p38-dependent activation of interferon regulatory factor 3 by lipopolysaccharide.

Authors:  L Navarro; M David
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

4.  Mass spectrometric proteomics profiles of in vivo tumor secretomes: capillary ultrafiltration sampling of regressive tumor masses.

Authors:  Chun-Ming Huang; Honnavara N Ananthaswamy; Stephen Barnes; Yuliang Ma; Mikako Kawai; Craig A Elmets
Journal:  Proteomics       Date:  2006-11       Impact factor: 3.984

Review 5.  Energy metabolism in tumor cells.

Authors:  Rafael Moreno-Sánchez; Sara Rodríguez-Enríquez; Alvaro Marín-Hernández; Emma Saavedra
Journal:  FEBS J       Date:  2007-03       Impact factor: 5.542

Review 6.  Anticancer function of polyinosinic-polycytidylic acid.

Authors:  Yu-sheng Cheng; Feng Xu
Journal:  Cancer Biol Ther       Date:  2010-12-15       Impact factor: 4.742

7.  Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes.

Authors:  F X Zhang; C J Kirschning; R Mancinelli; X P Xu; Y Jin; E Faure; A Mantovani; M Rothe; M Muzio; M Arditi
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

Review 8.  Molecular targets of the oncogenic transcription factor jun.

Authors:  M Hartl; A G Bader; K Bister
Journal:  Curr Cancer Drug Targets       Date:  2003-02       Impact factor: 3.428

9.  Proteomic analysis of the LPS-induced stress response in rat chondrocytes reveals induction of innate immune response components in articular cartilage.

Authors:  Lisbet Haglund; Suzanne M Bernier; Patrik Onnerfjord; Anneliese D Recklies
Journal:  Matrix Biol       Date:  2007-10-10       Impact factor: 11.583

10.  Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration.

Authors:  Anthony L Schwartz; Ramiro Malgor; Eric Dickerson; Ashani T Weeraratna; Andrzej Slominski; Jacobo Wortsman; Norikazu Harii; Aimee D Kohn; Randall T Moon; Frank L Schwartz; Douglas J Goetz; Leonard D Kohn; Kelly D McCall
Journal:  Clin Cancer Res       Date:  2009-05-26       Impact factor: 12.531

View more
  5 in total

1.  Inbred Substrain Differences Influence Neuroimmune Response and Drinking Behavior.

Authors:  Anna S Warden; Adriana DaCosta; Sonia Mason; Yuri A Blednov; Roy Dayne Mayfield; Robert Adron Harris
Journal:  Alcohol Clin Exp Res       Date:  2020-08-02       Impact factor: 3.455

2.  Inhibitory effects of luteolin on TLR3-mediated inflammation caused by TAK/NF-κB signaling in human corneal fibroblasts.

Authors:  Zi-Han Guo; Ping-Ping Liu; Heng Wang; Xiu-Xia Yang; Cheng-Cheng Yang; Hui Zheng; Dan Tang; Yang Liu
Journal:  Int J Ophthalmol       Date:  2022-03-18       Impact factor: 1.779

3.  Increased expression of Profilin potentiates chemotherapeutic agent-mediated tumour regression.

Authors:  Shashank Saurav; Sunil Kumar Manna
Journal:  Br J Cancer       Date:  2022-01-12       Impact factor: 9.075

4.  The nuclear factor-κB pathway down-regulates expression of the NKG2D ligand H60a in vitro: implications for use of nuclear factor-κB inhibitors in cancer therapy.

Authors:  Carlos Peinado; Xi Kang; Chanae Hardamon; Sumit Arora; Stephen Mah; Hui Zhang; Jennifer Ngolab; Jack D Bui
Journal:  Immunology       Date:  2013-06       Impact factor: 7.397

5.  Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells.

Authors:  Mathieu Veyrat; Sylvère Durand; Marion Classe; Tanja Matijevic Glavan; Natalie Oker; Nikiforos-Ioannis Kapetanakis; Xiaojun Jiang; Aurore Gelin; Philippe Herman; Odile Casiraghi; David Zagzag; David Enot; Pierre Busson; Benjamin Vérillaud
Journal:  Oncotarget       Date:  2016-12-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.